Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.

AIDS (London, England) - 1 Jul 2003

Vergne Laurence, Kane Coumba Touré, Laurent Christian, Diakhaté Ndella, Gueye Ndeye Fatou Ngom, Gueye Pape Mandoumbé, Sow Papa Salif, Faye Mame Awa, Liégeois Florian, Ndir Adama, Lanièce Isabelle, Peeters Martine, Ndoye Ibrahima, Mboup Souleymane, Delaporte Eric

Abstract excerpt

OBJECTIVE: To monitor the prevalence of antiretroviral (ARV)-resistant HIV-1 viruses, and the genotypic mutations in patients enrolled in the Senegalese initiative for access to antiretroviral treatment (ART). METHODS: A total of 80 patients with a virological follow-up of at least 6 months were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Developing Countries

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Senegal

Share to Viral Load

Source

Identifiers

PMID: 14565607
DOI: 10.1097/00002030-200317003-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14565607-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.PMID 14565607Read ↗

HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system.Semantic proximity Read ↗

Antiretroviral drug resistance mutations in antiretroviral-naive patients from Senegal.Semantic proximity Read ↗

Emergence of Multiclass Drug–Resistance in HIV‐2 in Antiretroviral‐Treated Individuals in Senegal: Implications for HIV‐2 Treatment in Resouce‐Limited West AfricaSemantic proximity Read ↗

High Rate Of Antiretroviral Drug Resistance Mutations in HIV Type 1-Infected Senegalese Children in Virological Failure on First-Line Treatment According to the World Health Organization GuidelinesSemantic proximity Read ↗

Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy.Semantic proximity Read ↗

High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.Semantic proximity Read ↗

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy.Semantic proximity Read ↗

Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal.Semantic proximity Read ↗

Moderate levels of pre-therapy drug resistance (PDR) in a generalised epidemic: time for better first-line ART?Semantic proximity Read ↗

The global status of resistance to antiretroviral drugs.Semantic proximity Read ↗

Genotypic resistance and the treatment of HIV-1 infection in Espírito Santo, Brazil.Semantic proximity Read ↗

Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy--implications for sustained efficacy of ART in resource-limited settings.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.